ARTICLE | Top Story
Spectrum in-licenses belinostat
February 3, 2010 12:32 AM UTC
TopoTarget A/S (CSE:TOPO) gained DKK1.73 (61%) to DKK4.57 on Tuesday after granting Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) rights to belinostat in North America and India, with an option for Chin...